Cargando…

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis

OBJECTIVES: Tolerogenic dendritic cells (tolDCs) constitute a promising experimental treatment for targeting autoreactive T cells in autoimmune diseases, including rheumatoid arthritis (RA). The authors' goal is to bring tolDC therapy for RA to the clinic. Here the authors address key translati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harry, Rachel A, Anderson, Amy E, Isaacs, John D, Hilkens, Catharien M U
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2010
Materias:	Basic and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002758/ https://www.ncbi.nlm.nih.gov/pubmed/20551157 http://dx.doi.org/10.1136/ard.2009.126383

Ejemplares similares

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Dendritic cell integrin expression patterns regulate inflammation in the rheumatoid arthritis joint
por: Schittenhelm, Leonie, et al.
Publicado: (2020)

Tolerogenic dendritic cells differentially modulate naïve and memory CD4(+ )T cells
por: Anderson, Amy E, et al.
Publicado: (2007)

A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease
por: Pratt, Arthur G, et al.
Publicado: (2012)

Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis
por: Spiering, Rachel, et al.
Publicado: (2019)

Generation of dexamethasone and vitamin D3-treated human monocyte-derived dendritic cells with tolerogenic properties
por: Sayers, Bethan, et al.
Publicado: (2007)

LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells
por: Anderson, Amy E., et al.
Publicado: (2009)

Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis
por: Reynolds, G, et al.
Publicado: (2016)

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)

Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration
por: Mansilla, María José, et al.
Publicado: (2023)

Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4(+) T Cells in a Murine Arthritis Model
por: Jansen, Manon A. A., et al.
Publicado: (2019)

Fluorine labelling of therapeutic human tolerogenic dendritic cells for (19)F-magnetic resonance imaging
por: Cooke, Fiona, et al.
Publicado: (2022)

Tolerogenic dendritic cell reporting: Has a minimum information model made a difference?
por: Sahar, Ayesha, et al.
Publicado: (2023)

Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis
por: Cooles, Faye A. H., et al.
Publicado: (2018)

IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis
por: Anderson, Amy E, et al.
Publicado: (2016)

Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort
por: Ten Brinke, Anja, et al.
Publicado: (2015)

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications
por: Yoo, Seungbo, et al.
Publicado: (2016)

Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4(+) T Cells
por: Maggi, Jaxaira, et al.
Publicado: (2016)

MICL controls inflammation in rheumatoid arthritis
por: Redelinghuys, Pierre, et al.
Publicado: (2016)

The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy
por: Cooles, Faye A.H., et al.
Publicado: (2018)

The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort
por: Smith, Samantha Louise, et al.
Publicado: (2017)

Thymic function in juvenile idiopathic arthritis
por: Lorenzi, A R, et al.
Publicado: (2008)

Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features
por: García-González, Paulina A., et al.
Publicado: (2016)

The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation
por: Tang, Man Wai, et al.
Publicado: (2016)

Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
por: Herenius, M M J, et al.
Publicado: (2011)

Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients
por: Kabala, Pawel A, et al.
Publicado: (2020)

Identification of a transitional fibroblast function in very early rheumatoid arthritis
por: Filer, Andrew, et al.
Publicado: (2017)

Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis
por: Tak, Paul P, et al.
Publicado: (2017)

Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis
por: Mo, Wen-Xiu, et al.
Publicado: (2017)

Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis
por: Genovese, Mark C, et al.
Publicado: (2018)

Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis
por: Montgomery, Anna B, et al.
Publicado: (2016)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis
por: Leonard, Dag, et al.
Publicado: (2018)

Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis
por: Yeo, Lorraine, et al.
Publicado: (2011)

Identification of the NF-κB activating protein-like locus as a risk locus for rheumatoid arthritis
por: Xie, Gang, et al.
Publicado: (2013)

Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis
por: Yeo, L, et al.
Publicado: (2016)

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis
por: Schwenzer, Anja, et al.
Publicado: (2016)

Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes
por: Angiolilli, Chiara, et al.
Publicado: (2017)

Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint
por: Smiljanovic, Biljana, et al.
Publicado: (2018)

Differential regulation of naïve and memory CD4(+) T cells by alternatively activated dendritic cells
por: Anderson, Amy E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fanhklf8im709ma8kdt326dibk